Related Experiment Video
Updated: Mar 18, 2026
06:58
An Application for Pairing with Wearable Devices to Monitor Personal Health Status
Published on: February 3, 2022
3.5K
Effects of combination approach on harm reduction programs: the Taiwan experience
Ting Lin1,2, Chang-Hsun Chen3, Pesus Chou4
1Community Medicine Research Center and Institute of Public Health, National Yang-Ming University, No.155, Section 2, Ni-Long Street, Taipei, 11221, Taiwan.
Harm Reduction Journal
|July 6, 2016
Summary
Comprehensive harm reduction programs effectively reduced HIV epidemics among Taiwanese injection drug users by addressing both addiction and needle-sharing. These programs, including needle exchange and opioid substitution therapy, reversed HIV growth and decreased infections.
Area of Science:
- Public Health
- Epidemiology
- Addiction Science
Background:
- Taiwan experienced a significant human immunodeficiency virus (HIV) epidemic among injection drug users starting in 2003.
- In response, comprehensive harm reduction programs were implemented in 2005 to combat HIV and illicit drug addiction.
Purpose of the Study:
- To analyze the impact of harm reduction programs on HIV and illicit drug use in Taiwan.
- To explore correlations between intervention phases and their combined effects on the HIV epidemic.
Main Methods:
- Utilized surveillance data and statistics from 2002-2015, divided into three intervention phases.
- Examined correlations between variables and combined intervention effects on HIV and drug abuse.
Main Results:
- The HIV epidemic peaked in 2005, coinciding with increased heroin users.
- Harm reduction programs, including needle exchange and opioid substitution therapy, halted HIV growth and led to a decline.
- Heroin use also decreased as these programs matured, with HIV levels falling below pre-outbreak levels.
Conclusions:
- Addressing both drug addiction and needle-sharing is crucial for managing HIV epidemics in injection drug users.
- Comprehensive, rapidly scaled-up harm reduction programs are effective in reversing HIV epidemics and reducing drug use.
- Further research is needed to understand reasons for declining opioid substitution therapy uptake to prevent future rebounds.
